»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Ç÷Àå ºÐȹ ½ÃÀåÀº 2024-2029³â¿¡ 156¾ï 8,510¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ Ç÷Àå ºÐȹ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ½ÃÀåÀº È£Èí±â Áúȯ ¹× AATD¸¦ Ä¡·áÇÏ´Â Ç÷Àå Á¦Ç°ÀÇ º¸±Þ, Ç÷Àå À¯·¡ Á¦Ç° ¸ñ·Ï Áõ°¡, Ç÷Àå ±â¹Ý Á¦Ç°À» Á¦Á¶ÇÏ´Â M&A Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ¿¬µµ
2025³â
Á¾·á¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
6.7%
CAGR
7.3%
Áõ°¡¾×
156¾ï 8,510¸¸ ´Þ·¯
º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
º» Á¶»ç´Â ÇâÈÄ ¸î ³â µ¿¾È Ç÷Àå ºÐȹ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ³ëÀÎ Àα¸ Áõ°¡¿Í °ü·Ã Àå¾Ö¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Ç÷Àå Á¦Ç°ÀÇ ÀÚ±Þ·ü Çâ»óÀ» À§ÇÑ Á¤ºÎ Àü·«°ú Ç÷Àå äÃë ¼ö¿ä Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2024³â)
½ÃÀå Àü¸Á(2024-2029³â)
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ Ç÷Àå ºÐȹ ½ÃÀå(2019-2023³â)
Á¦Ç°º° ºÎ¹® ºÐ¼®(2019-2023³â)
¿ëµµº° ºÎ¹® ºÐ¼®(2019-2023³â)
±â¼úº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ Ç÷Àå ºÐȹ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç°º°
½ÃÀå ºÎ¹®
ºñ±³ : Á¦Ç°º°
¸é¿ª±Û·ÎºÒ¸° : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾ËºÎ¹Î : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÀ°íÀÎÀÚ ³óÃ๰ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ·ÎÅ×¾ÆÁ¦ ¾ïÁ¦Á¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Á¦Ç°º°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
¸é¿ªÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½Å°æÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Ç÷¾×ÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÁýÁß Ä¡·á : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¿ëµµº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ±â¼úº°
½ÃÀå ºÎ¹®
ºñ±³ : ±â¼úº°
Å©·Î¸¶Åä±×·¡ÇÇ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿©°ú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ħÀü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ±â¼úº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
ÆÄ±«Àû Çõ½Å »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
ADMA Biologics Inc.
Bharat Serums and Vaccines Ltd.
CSL Ltd.
Emergent BioSolutions Inc.
GC Biopharma Corp.
Grifols SA
Intas Pharmaceuticals Ltd.
Kamada Ltd.
Kedrion SpA
LFB SA
Merck KGaA
Octapharma AG
Sanquin
SK Inc.
Takeda Pharmaceutical Co. Ltd.
Á¦16Àå ºÎ·Ï
LSH
The plasma fractionation market is forecasted to grow by USD 15,685.1 mn during 2024-2029, accelerating at a CAGR of 7.3% during the forecast period. The report on the plasma fractionation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of plasma products treated in respiratory diseases and aatd, growing list of plasma-derived products, and increasing in mergers and acquisitions producing plasma-based products.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 6.7%
CAGR 7.3%
Incremental Value $15,685.1 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's plasma fractionation market is segmented as below:
By Product
Immunoglobulins
Albumin
Coagulation factor concentrates
Protease inhibitors
Others
By Application
Immunology
Neurology
Hematology
Critical care
Others
By Technology
Chromatography
Filtration
Precipitation
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the growing elderly population and related disorders as one of the prime reasons driving the plasma fractionation market growth during the next few years. Also, government strategies for increasing self-sufficiency for plasma products and rising demand for plasma collection will lead to sizable demand in the market.
The report on the plasma fractionation market covers the following areas:
Plasma Fractionation Market sizing
Plasma Fractionation Market forecast
Plasma Fractionation Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma fractionation market vendors that include ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma Corp., Grifols SA, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion SpA, LFB SA, Merck KGaA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd.. Also, the plasma fractionation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Plasma Fractionation Market 2019 - 2023
Historic Market Size - Data Table on Global Plasma Fractionation Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in the global plasma fractionation market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Immunoglobulins - Market size and forecast 2024-2029
Chart on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
Data Table on Immunoglobulins - Market size and forecast 2024-2029 ($ million)
Chart on Immunoglobulins - Year-over-year growth 2024-2029 (%)
Data Table on Immunoglobulins - Year-over-year growth 2024-2029 (%)
8.4 Albumin - Market size and forecast 2024-2029
Chart on Albumin - Market size and forecast 2024-2029 ($ million)
Data Table on Albumin - Market size and forecast 2024-2029 ($ million)
Chart on Albumin - Year-over-year growth 2024-2029 (%)
Data Table on Albumin - Year-over-year growth 2024-2029 (%)
8.5 Coagulation factor concentrates - Market size and forecast 2024-2029
Chart on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
Data Table on Coagulation factor concentrates - Market size and forecast 2024-2029 ($ million)
Chart on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
Data Table on Coagulation factor concentrates - Year-over-year growth 2024-2029 (%)
8.6 Protease inhibitors - Market size and forecast 2024-2029
Chart on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
Data Table on Protease inhibitors - Market size and forecast 2024-2029 ($ million)
Chart on Protease inhibitors - Year-over-year growth 2024-2029 (%)
Data Table on Protease inhibitors - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Application
9.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
9.3 Immunology - Market size and forecast 2024-2029
Chart on Immunology - Market size and forecast 2024-2029 ($ million)
Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
Chart on Immunology - Year-over-year growth 2024-2029 (%)
Data Table on Immunology - Year-over-year growth 2024-2029 (%)
9.4 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
9.5 Hematology - Market size and forecast 2024-2029
Chart on Hematology - Market size and forecast 2024-2029 ($ million)
Data Table on Hematology - Market size and forecast 2024-2029 ($ million)
Chart on Hematology - Year-over-year growth 2024-2029 (%)
Data Table on Hematology - Year-over-year growth 2024-2029 (%)
9.6 Critical care - Market size and forecast 2024-2029
Chart on Critical care - Market size and forecast 2024-2029 ($ million)
Data Table on Critical care - Market size and forecast 2024-2029 ($ million)
Chart on Critical care - Year-over-year growth 2024-2029 (%)
Data Table on Critical care - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Technology
10.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
10.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
10.3 Chromatography - Market size and forecast 2024-2029
Chart on Chromatography - Market size and forecast 2024-2029 ($ million)
Data Table on Chromatography - Market size and forecast 2024-2029 ($ million)
Chart on Chromatography - Year-over-year growth 2024-2029 (%)
Data Table on Chromatography - Year-over-year growth 2024-2029 (%)
10.4 Filtration - Market size and forecast 2024-2029
Chart on Filtration - Market size and forecast 2024-2029 ($ million)
Data Table on Filtration - Market size and forecast 2024-2029 ($ million)
Chart on Filtration - Year-over-year growth 2024-2029 (%)
Data Table on Filtration - Year-over-year growth 2024-2029 (%)
10.5 Precipitation - Market size and forecast 2024-2029
Chart on Precipitation - Market size and forecast 2024-2029 ($ million)
Data Table on Precipitation - Market size and forecast 2024-2029 ($ million)
Chart on Precipitation - Year-over-year growth 2024-2029 (%)
Data Table on Precipitation - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 ADMA Biologics Inc.
ADMA Biologics Inc. - Overview
ADMA Biologics Inc. - Business segments
ADMA Biologics Inc. - Key news
ADMA Biologics Inc. - Key offerings
ADMA Biologics Inc. - Segment focus
SWOT
15.5 Bharat Serums and Vaccines Ltd.
Bharat Serums and Vaccines Ltd. - Overview
Bharat Serums and Vaccines Ltd. - Product / Service
Bharat Serums and Vaccines Ltd. - Key offerings
SWOT
15.6 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
SWOT
15.7 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product / Service
Emergent BioSolutions Inc. - Key offerings
SWOT
15.8 GC Biopharma Corp.
GC Biopharma Corp. - Overview
GC Biopharma Corp. - Product / Service
GC Biopharma Corp. - Key offerings
SWOT
15.9 Grifols SA
Grifols SA - Overview
Grifols SA - Business segments
Grifols SA - Key news
Grifols SA - Key offerings
Grifols SA - Segment focus
SWOT
15.10 Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. - Overview
Intas Pharmaceuticals Ltd. - Product / Service
Intas Pharmaceuticals Ltd. - Key offerings
SWOT
15.11 Kamada Ltd.
Kamada Ltd. - Overview
Kamada Ltd. - Business segments
Kamada Ltd. - Key offerings
Kamada Ltd. - Segment focus
SWOT
15.12 Kedrion SpA
Kedrion SpA - Overview
Kedrion SpA - Product / Service
Kedrion SpA - Key offerings
SWOT
15.13 LFB SA
LFB SA - Overview
LFB SA - Product / Service
LFB SA - Key offerings
SWOT
15.14 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
15.15 Octapharma AG
Octapharma AG - Overview
Octapharma AG - Product / Service
Octapharma AG - Key offerings
SWOT
15.16 Sanquin
Sanquin - Overview
Sanquin - Product / Service
Sanquin - Key offerings
SWOT
15.17 SK Inc.
SK Inc. - Overview
SK Inc. - Product / Service
SK Inc. - Key offerings
SWOT
15.18 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations